Asset Details
MbrlCatalogueTitleDetail
Do you wish to reserve the book?
Bone turnover markers to explain changes in lumbar spine BMD with abaloparatide and teriparatide: results from ACTIVE
by
Mitlak, B H
, Fitzpatrick, L A
, Wang, Y
, M Hu
, Black, D M
, Eastell, R
in
Bone growth
/ Bone mineral density
/ Bone resorption
/ Bone turnover
/ Collagen
/ Dual energy X-ray absorptiometry
/ Osteogenesis
/ Osteoporosis
/ Parathyroid hormone
/ Patients
/ Spine (lumbar)
/ Vitamin D
2019
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
You are currently in the queue to collect this book. You will be notified once it is your turn to collect the book.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Bone turnover markers to explain changes in lumbar spine BMD with abaloparatide and teriparatide: results from ACTIVE
by
Mitlak, B H
, Fitzpatrick, L A
, Wang, Y
, M Hu
, Black, D M
, Eastell, R
in
Bone growth
/ Bone mineral density
/ Bone resorption
/ Bone turnover
/ Collagen
/ Dual energy X-ray absorptiometry
/ Osteogenesis
/ Osteoporosis
/ Parathyroid hormone
/ Patients
/ Spine (lumbar)
/ Vitamin D
2019
Oops! Something went wrong.
While trying to remove the title from your shelf something went wrong :( Kindly try again later!
Do you wish to request the book?
Bone turnover markers to explain changes in lumbar spine BMD with abaloparatide and teriparatide: results from ACTIVE
by
Mitlak, B H
, Fitzpatrick, L A
, Wang, Y
, M Hu
, Black, D M
, Eastell, R
in
Bone growth
/ Bone mineral density
/ Bone resorption
/ Bone turnover
/ Collagen
/ Dual energy X-ray absorptiometry
/ Osteogenesis
/ Osteoporosis
/ Parathyroid hormone
/ Patients
/ Spine (lumbar)
/ Vitamin D
2019
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Bone turnover markers to explain changes in lumbar spine BMD with abaloparatide and teriparatide: results from ACTIVE
Journal Article
Bone turnover markers to explain changes in lumbar spine BMD with abaloparatide and teriparatide: results from ACTIVE
M Hu,
2019
Request Book From Autostore
and Choose the Collection Method
Overview
SummaryEarly PINP changes correlate with 18-month lumbar spine BMD changes and the correlation was greater with abaloparatide versus teriparatide. The uncoupling index was similar between the two agents.IntroductionWe evaluated the relationship between early PINP changes and subsequent changes in spine BMD following abaloparatide and teriparatide treatments. We also explored the use of an “uncoupling index” (UI), the balance between bone formation and bone resorption, which we hypothesised would be similar in response to these treatment groups.MethodsBlood samples were taken for measurement of bone turnover markers (BTMs) s-PINP and s-CTX at baseline, 1, 3, 6, 12, and 18 months from 189 abaloparatide patients and 227 teriparatide patients randomly selected from all participants who completed the study. BMD was measured by DXA at baseline, 6, 12, and 18 months. Correlations were calculated between log ratio of BTMs from baseline to 3 months and percent change from baseline in BMD at 18 months. A UI was calculated using log transformation and subtraction of the standard deviate for s-CTX from the standard deviate for s-PINP for each patient.ResultsEarly BTM changes were associated with subsequent BMD changes for both treatments. Pearson correlations for the log ratio of PINP over baseline at 3 months and BMD percent change from baseline at 18 months were larger (P < 0.0001) with abaloparatide (r = 0.561) than teriparatide (r = 0.198). The mean UI at 1 month was greater for abaloparatide versus teriparatide (1.743 and 1.493, respectively; P = 0.03) but was similar at 3 months or later time points.ConclusionsEarly s-PINP changes correlate with percentage change in lumbar spine BMD 18 months after treatment with both abaloparatide and teriparatide, though the correlation with abaloparatide was greater. The UI was similar between abaloparatide and teriparatide suggesting that the balance between formation and resorption markers was similar.
Publisher
Springer Nature B.V
This website uses cookies to ensure you get the best experience on our website.